Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Applied Therapeutics Inc. | aplt-20201231ex322b78357.htm |
| EX-32.1 - EX-32.1 - Applied Therapeutics Inc. | aplt-20201231ex3211f16ab.htm |
| EX-31.2 - EX-31.2 - Applied Therapeutics Inc. | aplt-20201231ex31281a89b.htm |
| EX-31.1 - EX-31.1 - Applied Therapeutics Inc. | aplt-20201231ex3118c782a.htm |
| EX-3.3 - EX-3.3 - Applied Therapeutics Inc. | aplt-20201231ex33a46ecb9.htm |
| 10-K - 10-K - Applied Therapeutics Inc. | aplt-20201231x10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
| ● | Registration Statement (Form S-8 No. 333-231618) of Applied Therapeutics Inc., and |
| ● | Registration Statement (Form S-3 No. 333-238948) of Applied Therapeutics Inc. |
of our report dated March 18, 2021, with respect to the financial statements of Applied Therapeutics, Inc. included in this Annual Report (Form 10-K) of Applied Therapeutics for the year ended December 31, 2020.
|
/s/ Ernst & Young LLP |
New York, New York |
March 18, 2021 |
|